Biotech News

CLEAR To Announce Second Quarter 2026 Financial Results On August 5, 2026

Clear Secure Inc (YOU)Clear Secure IncEarnings

, /PRNewswire/ -- Clear Secure, Inc. (NYSE: YOU), the secure identity company, today announced that it will report financial results for the second quarter ending June 30, 2026 at approximately 6:00 a.m. ET on Wednesday, August 5, 2026. At 8:00 a.m. ET, results will be discussed via live webcast and teleconference.

Investors and analysts can access the live teleconference call by dialing toll-free 877-407-3089 for U.S. participants and +1 215-268-9854 for international participants. Listeners can access the live webcast HERE . A webcast replay will be available after the event on the investor relations website at https://ir.clearme.com .

About CLEAR The mission of CLEAR, the secure identity company, is to strengthen security and create frictionless experiences. With over 41 million Members and a growing network of partners across the world, CLEAR's secure identity platform is transforming the way people live, work, and travel. Whether you are traveling, at the stadium, or on your phone, CLEAR connects you to the things that make you, you—making everyday experiences easier, more secure, and friction-free. CLEAR is committed to privacy done right. Members are always in control of their own information, and we do not sell biometric or sensitive personal data. For more information, visit clearme.com.

Investor Contact [email protected]

Media Contact [email protected]

View original content to download multimedia: https://www.prnewswire.com/news-releases/clear-to-announce-second-quarter-2026-financial-results-on-august-5-2026-302831119.html

SOURCE CLEAR

Released July 22, 2026

Open original release

Related news

Clear Secure Inc

Clear Secure is a consumer identity and security company best known for its biometric identity platform at airports and stadiums. The business is centered on identity verification and access rather than healthcare or biotech.

Recent company news

Stock data

Close
53.23 USD
Market cap
5.72B USD
Exchange
NYSE
Sector
Biopharma
Location
United States